Literature DB >> 15625533

Methyltransferase inhibitors: changing the treatment algorithm for myelodysplastic syndromes.

Alan List1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15625533     DOI: 10.1177/10732748040110S605

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


× No keyword cloud information.
  1 in total

1.  Decitabine for Treatment of Myelodysplastic Syndromes in Chinese Patients: An Open-Label, Phase-3b Study.

Authors:  Depei Wu; Xin Du; Jie Jin; Zhijian Xiao; Zhixiang Shen; Zonghong Shao; Xiao Li; Xiaojun Huang; Ting Liu; Li Yu; Jianyong Li; Baoan Chen; Guangsheng He; Zhen Cai; Hongchuang Liang; Jigang Li; Changgeng Ruan
Journal:  Adv Ther       Date:  2015-11-14       Impact factor: 3.845

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.